Loading…
Loading…

| LLYLLYEli Lilly and Company | Eli Lilly and Company | $1,273.46 | $1.2T |
| MRKMRKMerck & Co., Inc. | Merck & Co., Inc. | $145.27 | $358.4B |
| NVSNVSNovartis AG | Novartis AG | $151.12 | $287.2B |
| AZNAZNAstraZeneca PLC | AstraZeneca PLC | $171.49 | $266.0B |
| AMGNAMGNAmgen Inc. | Amgen Inc. | $439.26 | $237.5B |
| GILDGILDGilead Sciences, Inc. | Gilead Sciences, Inc. | $156.04 | $193.5B |
| NVONVONovo Nordisk A/S | Novo Nordisk A/S | $39.05 | $172.3B |
| PFEPFEPfizer Inc. | Pfizer Inc. | $30.03 | $171.2B |
| BMYBMYBristol-Myers Squibb Company | Bristol-Myers Squibb Company | $61.48 | $125.6B |
| GSKGSKGSK plc | GSK plc | $50.75 | $101.7B |